Medtronic MDT Medical Surgical — Selling, general, and administrative expense
Other segment segments
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Medtronic in its filing.
Tagged under the XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense.
The official record: Medtronic’s 10-K, filed June 18, 2026, on SEC EDGAR. View the filing →
Ask your AI about Medtronic's medical surgical — selling, general, and administrative expense.
Connect your AI assistant and compare segments, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Medtronic's medical surgical — selling, general, and administrative expense?
- Medtronic (MDT) reported medical surgical — selling, general, and administrative expense of $650M in Q1 2026.
- How has Medtronic's medical surgical — selling, general, and administrative expense changed year-over-year?
- Medtronic's medical surgical — selling, general, and administrative expense increased by 9.6% year-over-year, from $593M to $650M.
- What is the long-term trend for Medtronic's medical surgical — selling, general, and administrative expense?
- Over 3 years (2023 to 2026), Medtronic's medical surgical — selling, general, and administrative expense has grown at a 17.5% compound annual growth rate (CAGR), from $1.55B to $2.51B.
- What does medical surgical — selling, general, and administrative expense mean?
- The costs of selling, marketing, and administrative support for the Medical Surgical segment.
- How do you interpret medical surgical — selling, general, and administrative expense?
- A lower ratio of SG&A to sales suggests improved operational efficiency and better scalability of the sales organization.
- How does medical surgical — selling, general, and administrative expense compare across companies?
- Standard SG&A expense reporting for medical device business units.